Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 283

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 16G
Chunk 283
---
Item
16G. Corporate Governance

As
an Israeli company, we are subject to various corporate governance requirements under the Companies Law, relating to matters such as
external directors, the audit committee, the compensation committee and an internal auditor.

We
are a “foreign private issuer”, as such term is defined in Rule 405 under the Securities Act. As a foreign private issuer
we will be permitted to comply with Israeli corporate governance practices instead of the certain listing rules of Nasdaq, provided that
we disclose which requirements we are not following and the equivalent Israeli requirements.

  Quorum.                                                                                            

  Shareholder                                                                                      

  Adoption                                                                                            

We
otherwise intend to comply with the rules generally applicable to U. S. domestic companies listed on the Nasdaq. We may, however, in the
future decide to rely upon the “foreign private issuer exemption” for purposes of opting out of some or all of the other
Nasdaq listing rules.

Item
16H. Mine Safety Disclosure